Neisseria meningitidis pili induce type-IIA phospholipase A2 expression in alveolar macrophages

Lhousseine Touqui1, Miguel Paya, Françoise Thouron

  • 1Unité de Défense Innée et Inflammation, Inserm E-336, Institut Pasteur, 25 rue du Dr. Roux, 75015 Paris, France. touqui@pasteur.fr

FEBS Letters
|August 24, 2005
PubMed

Insights

Bacterial pili, not just lipooligosaccharide, trigger alveolar macrophages to produce type-IIA secreted phospholipase A2 (sPLA2-IIA) via a nuclear factor kappa B (NF-kappaB) pathway.

Area of Science:

  • Immunology
  • Microbiology
  • Molecular Biology

Background:

  • Type-IIA secreted phospholipase A2 (sPLA2-IIA) plays a role in inflammatory responses.
  • The induction of sPLA2-IIA by bacterial components beyond lipopolysaccharide (LPS) is not well understood.

Purpose of the Study:

  • To investigate the role of Neisseria meningitidis components, particularly pili, in inducing sPLA2-IIA expression in alveolar macrophages (AM).

Main Methods:

  • Exposure of AM to wild-type and mutant strains of N. meningitidis, including lipooligosaccharide (LOS)-deficient and pili-defective mutants.
  • Analysis of sPLA2-IIA synthesis and nuclear factor kappa B (NF-kappaB) activation.

Main Results:

  • Both wild-type N. meningitidis and its LOS induced sPLA2-IIA synthesis in AM.
  • A mutant lacking LOS still induced sPLA2-IIA, indicating other factors are involved.
  • Pili isolated from a LOS-defective strain induced sPLA2-IIA expression and NF-kappaB activation, suggesting pili are key inducers.

Conclusions:

  • Bacterial pili are potent inducers of sPLA2-IIA expression in alveolar macrophages.
  • This induction occurs through a NF-kappaB-dependent signaling pathway.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...